Infiniti Research is a leading provider of market intelligence services to businesses around the globe. For over 15 years, Infiniti has been helping companies across industries to identify key market challenges and strategize to meet the changing market demands. In their recent article, experts at Infiniti Research give comprehensive insights on how companies can leverage maximum value from pharma M&A deals.
Why partner with us?
The pharmaceutical industry is one of the major sectors that is actively involved in huge mergers and acquisition (M&A) deals, both in terms of numbers of deals and the amount of money spent. Most companies in the sector, especially the big pharma, consider pharma M&A as a major factor to bolster innovation and overall growth. Pharma M&A has become a common practice for companies that have non-diverse pipelines or have top revenue drugs that are nearing patent expiration and subsequent generic erosion. According to industry experts at Infiniti Research, some of the key reasons why companies favor pharma M&A include critical size requirements across various market segments, bundling of sub-critical businesses, and to capture annual cost synergies by scaling up. For more insights on key considerations for successful pharma M&A.
Source: Olean Times Herald
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
